Application | Comment | Organism |
---|---|---|
medicine | histone demethylase JMJD3 might serve as a therapeutic target for treatment of systemic lupus erythematosus, SLE | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
overexpression of JMJD3 through the transfection of pcDNA3.1-JMJD3 into healthy donor CD4+ T cells leading to an increase in JMJD3 enrichment, a decrease in H3K27me3 enrichment within the ITGAL (CD11a) promoter, and upregulation of CD11a expression, resulting in T and B cell hyperactivity | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | after transfecting the JMJD3 expression plasmid into normal CD4+ T cells isolated from healthy donors, upregulation of JMJD3 binding and the reduction of H3K27me3 enrichment within the CD11a promoter occurs, which increases CD11a expression and enhanced T cell auto-reactivity. In contrast, downregulation of JMJD3 by siRNA-mediated knockdown, reduces JMJD3 binding and increases H3K27me3 enrichment within the CD11a promoter, which suppresses CD11a expression and reverses the auto-reactivity of T cells in systemic lupus erythematosus patients | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
histone H3 N6,N6,N6-trimethyl-L-lysine27 + 2-oxoglutarate + O2 | Homo sapiens | - |
histone H3 N6,N6-dimethyl-L-lysine27 + succinate + formaldehyde + CO2 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O15054 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
T-lymphocyte | CD4+ cells, expression analysis of enzyme in cells from healthy persons and systemic lupus erythematosus patients: significantly decreased H3K27me3 levels and increased JMJD3 binding are detected within the ITGAL (CD11a) promoter locus in SLE CD4+ T cells compared with those in healthy CD4+ T cells | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
histone H3 N6,N6,N6-trimethyl-L-lysine27 + 2-oxoglutarate + O2 | - |
Homo sapiens | histone H3 N6,N6-dimethyl-L-lysine27 + succinate + formaldehyde + CO2 | - |
? |
Synonyms | Comment | Organism |
---|---|---|
histone demethylase | - |
Homo sapiens |
JMJD3 | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | JMJD3, as a histone demethylase, is capable of specifically removing the trimethyl group from the H3K27 lysine residue, triggering target gene activation. Histone demethylase JMJD3 regulates CD11a expression in lupus T cells through changes in histone H3K27 tri-methylation levels in CD4+ T cells of patients with systemic lupus erythematosus by affecting the H3K27me3 levels in the ITGAL (CD11a) promoter region. The monomethylation of H3K27 (H3K27me) is associated with gene activation, whereas H3K27me3 is associated with gene repression | Homo sapiens |